Showing results (461-470 of 1,386) with videos related to

Sort By:
Pageof 139
Neuropsychobiology|January 1, 1996
Effects of anxiety and memory of systemic and intra-amygdala injection of 5-HT3 receptor antagonist BRL 46470AP A Gargiulo, M B Viana, F G Graeff, et al.
International Journal of Cardiology|December 1, 1992
Effects of dopaminergic agents on cardiac and renal function in normal man and in patients with congestive heart failureD J van Veldhuisen, A R Girbes, P A de Graeff, et al.
Gastroenterology|March 1, 1984
Hypogammaglobulinemia due to abnormal suppressor T-cell activity in Crohn's diseaseC O Elson, S P James, A S Graeff, et al.
Der Pathologe|March 11, 2004
[Therapy-related changes of angiogenesis in Philadelphia chromosome positive chronic myelogenous leukemia]H M Kvasnicka, J Thiele, P Staib, et al.
International Journal of Oncology|October 17, 1998
Multifunctional potential of the plasminogen activation system in tumor invasion and metastasis (review)U Reuning, V Magdolen, O Wilhelm, et al.
Cancer Research|May 15, 1994
Both the cytosols and detergent extracts of breast cancer tissues are suited to evaluate the prognostic impact of the urokinase-type plasminogen activator and its inhibitor, plasminogen activator inhibitor type 1F Jänicke, L Pache, M Schmitt, et al.
The Journal of Physical Chemistry. B|October 30, 2008
Hierarchical and helical self-assembly of ADP-ribosyl cyclase into large-scale protein microtubesQun Liu, Irina A Kriksunov, Zhongwu Wang, et al.
Journal of Cardiovascular Electrophysiology|December 8, 2015
Treatment Planning Studies in Patient Data With Scanned Carbon Ion Beams for Catheter-Free Ablation of Atrial FibrillationAnna Constantinescu, H Immo Lehmann, Douglas L Packer, et al.
Journal of Psychopharmacology (Oxford, England)|October 16, 2014
Interaction between μ-opioid and 5-HT1A receptors in the regulation of panic-related defensive responses in the rat dorsal periaqueductal greyMarcel P Rangel, Hélio Zangrossi, Camila M Roncon, et al.
Physics in Medicine and Biology|November 23, 2017
Treatment planning with intensity modulated particle therapy for multiple targets in stage IV non-small cell lung cancerKristjan Anderle, Joep Stroom, Sandra Vieira, et al.
Pageof 139